Often called the “disease of kings” because of its association with the rich foods and copious alcohol once available only to aristocrats, gout is staging a middle-class comeback as American society grows older and heavier. The NY Times reports.

The Food and Drug Administration said Friday that the company's drug Krystexxa appears to successfully treat gout, despite evidence of potentially deadly side effects.